An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...

Dr. Deepa Jagadeesh discusses Ordspono's potential FDA approval for relapsed/refractory follicular lymphoma, highlighting its manageable toxicity and low CRS rate.

The Pullman Fire Department recently participated in a stair climb fundraiser organized by the Leukemia and Lymphoma Society.

The Scotia-Glenville Central School District says their team, “Rays of Hope,” is committed to the Leukemia and Lymphoma ...

EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...

Investing.com -- The European Commission has granted Bristol Myers (NYSE: BMY) Squibb, the biopharmaceutical company based in ...

In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...

Lymphoma causes symptoms of organ failure before death. Learn what patients in palliative or hospice care could experience ...

T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...

By comparing tattoo patterns alongside cancer diagnoses, researchers found that people with tattoos have a higher occurrence ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

Living with follicular lymphoma, I challenge common misconceptions about cancer, highlighting the unique and varied ...